Tarsus Pharmaceuticals (TARS) logo

TARS earnings date, and what happened the last 4 times

Next report

Wed Nov 4

Quality Score today 6

Before the open, in 9 days. Expected: the company has not confirmed it.

TARS closed higher after 2 of its last 4 reports. On average it closed +2.1% the session after a report.

The moment TARS reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when TARS reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after TARS's last 4 reports

TARS's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 6, 20262026 · Before open2estimated-6.0%+6.6%
May 6, 20262026 · After close4estimated-3.2%-1.2%
Feb 23, 20262026 · After close9estimated+7.1%+7.8%
Nov 4, 20252025 · After close15estimated-4.2%-4.6%
  • Aug 6, 2026, before the open: that session TARS opened -6.0% and closed +6.6%, and five sessions on it stood +14.2%. Its Quality Score going in was 2 (Below Average), estimated.
  • May 6, 2026, after the close: the next session TARS opened -3.2% and closed -1.2%, and five sessions on it stood -0.1%. Its Quality Score going in was 4 (Below Average), estimated.
  • Feb 23, 2026, after the close: the next session TARS opened +7.1% and closed +7.8%, and five sessions on it stood +11.3%. Its Quality Score going in was 9 (Average), estimated.
  • Nov 4, 2025, after the close: the next session TARS opened -4.2% and closed -4.6%, and five sessions on it stood +5.8%. Its Quality Score going in was 15 (Excellent), estimated.

Across these 4 reports TARS opened higher after 1 of 4 and closed higher after 2 of 4; on average it opened -1.6%, closed +2.1%, and stood +7.8% five sessions on. Its Quality Score is 6 today, against 2 going into its Aug 6, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +7.8% after the Feb 23, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see TARS's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about TARS's earnings

As of Oct 26, 2026: Tarsus Pharmaceuticals (TARS): expected to report Wed Nov 4, before the open. TARS closed higher after 2 of its last 4 reports. Its Quality Score is 6 (Average). Scores as of 10:16 PM ET, 15 minutes behind.

When is TARS's next earnings date?

Expected to report Wed Nov 4, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. TARS closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does TARS report before or after the market?

TARS is expected to report Wed Nov 4, before the open. Its last 4 reports came 3 after the close and 1 before the open.

How did TARS stock react to its last earnings report?

Aug 6, 2026, before the open: that session TARS opened -6.0% and closed +6.6%, and five sessions on it stood +14.2%.

Does TARS stock usually go up after earnings?

TARS closed higher after 2 of its last 4 reports. On average it closed +2.1% the session after a report, after opening -1.6%. Past behavior, not a forecast.

Tarsus Pharmaceuticals' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: next week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.